Why Emergent BioSolutions Stock Is Tumbling Today

Keith Speights, The Motley Fool
·2-min read
Why Emergent BioSolutions Stock Is Tumbling Today

The company has halted production of COVID-19 vaccines at its Baltimore facility as an FDA inspection moves forward.